Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acids, Carbocyclic 1
- Adolescent 1
- Adult 1
- Age Factors 1
- Amantadine 1
- Amino Acid Substitution 3
- Antigenic Variation 1
- antimicrobial resistance 1
- Antiviral Agents 4
- Article 2
- baloxavir 1
- baloxavir acid 1
- baloxavir marboxil 1
- cap-dependent endonuclease inhibitor 1
- Child 1
- Child, Preschool 1
- Cyclopentanes 2
- Dispatch 1
- Drug Resistance, Viral 4
- Enzyme Inhibitors 2
- Epidemiological Monitoring 1
- family cluster 1
- Female 1
- Global Health 2
- Guanidines 2
- H3N2 1
- Hemagglutination Inhibition Tests 2
- human-to-human transmission 1
- Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019 1
- Humans 5
- I38T substitution 1
- Infant 1
- Infant, Newborn 1
- influenza 1
- Influenza, Human 5
- influenza A(H1N1)pdm09 1
- Influenza A virus 2
- Influenza A Virus, H1N1 Subtype 3
- Influenza B virus 2
- influenza virus 1
- Inhibitor 1
- Inhibitory Concentration 50 1
- Male 1
- Markers 1
- Microbial Sensitivity Tests 2
- Middle Aged 1
- Mutation 1
- Neuraminidase 4
- Oseltamivir 4
- Pandemics 1
- Perspective 1
- Phylogeny 2
- Phylogeography 1
- polymerase acidic 1
- Pyrans 1
- Resistance 1
- respiratory infections 1
- Seasons 3
- Sequence Analysis, DNA 1
- Sequence Analysis, Protein 1
- Sialic Acids 1
- Surveillance 1
- Susceptibility 1
- Time Factors 1
- Viral Matrix Proteins 1
- viruses 1
- whole-genome sequencing 1
- World Health Organization 1
- Young Adult 1
- Zanamivir 3
Personal Author
Corporate Author
Place as Subject
- Japan 3
Resource Type General
Keywords
Select all docs (Max 200)
1 -
7 of 7 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acids, Carbocyclic (1)
- Adolescent (1)
- Adult (1)
- Age Factors (1)
- Amantadine (1)
- Amino Acid Substitution (3)
- Antigenic Variation (1)
- antimicrobial resistance (1)
- Antiviral Agents (4)
- Article (2)
- baloxavir (1)
- baloxavir acid (1)
- baloxavir marboxil (1)
- cap-dependent endonuclease inhibitor (1)
- Child (1)
- Child, Preschool (1)
- Cyclopentanes (2)
- Dispatch (1)
- Drug Resistance, Viral (4)
- Enzyme Inhibitors (2)
- Epidemiological Monitoring (1)
- family cluster (1)
- Female (1)
- Global Health (2)
- Guanidines (2)
- H3N2 (1)
- Hemagglutination Inhibition Tests (2)
- human-to-human transmission (1)
- Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019 (1)
- Humans (5)
- I38T substitution (1)
- Infant (1)
- Infant, Newborn (1)
- influenza (1)
- Influenza, Human (5)
- influenza A(H1N1)pdm09 (1)
- Influenza A virus (2)
- Influenza A Virus, H1N1 Subtype (3)
- Influenza B virus (2)
- influenza virus (1)
- Inhibitor (1)
- Inhibitory Concentration 50 (1)
- Male (1)
- Markers (1)
- Microbial Sensitivity Tests (2)
- Middle Aged (1)
- Mutation (1)
- Neuraminidase (4)
- Oseltamivir (4)
- Pandemics (1)
- Perspective (1)
- Phylogeny (2)
- Phylogeography (1)
- polymerase acidic (1)
- Pyrans (1)
- Resistance (1)
- respiratory infections (1)
- Seasons (3)
- Sequence Analysis, DNA (1)
- Sequence Analysis, Protein (1)
- Sialic Acids (1)
- Surveillance (1)
- Susceptibility (1)
- Time Factors (1)
- Viral Matrix Proteins (1)
- viruses (1)
- whole-genome sequencing (1)
- World Health Organization (1)
- Young Adult (1)
- Zanamivir (3)
- :Gubareva, Larisa V. ;Besselaar, Terry G.August 10 2017 | Antiviral Res. 2017; 146:12-20:Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillan...
- :Bedford, Trevor ;Riley, StevenJun 08 2015 | Nature. 523(7559):217-220.:Understanding the spatiotemporal patterns of emergence and circulation of new human seasonal influenza virus variants is a key scientific and public h...
- :Barr, Ian G. ;Donis, Ruben O.Oct 09 2018 | NPJ Vaccines. 3.:The 2017-2018 seasonal influenza epidemics were severe in the US and Australia where the A(H3N2) subtype viruses predominated. Although circulating A(...
- :Ujike, Makoto ;Ejima, MihoMar 2011 | Emerg Infect Dis. 17(3):470-479.:To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mutation, we analyzed 4,307 clinical specimens from J...
- :Ujike, Makoto ;Shimabukuro, KozueJun 2010 | Emerg Infect Dis. 16(6):926-935.:To monitor oseltamivir-resistant influenza viruses A (H1N1) (ORVs) with H275Y in neuraminidase (NA) in Japan during 2 influenza seasons, we analyzed 3...
- :Takashita, Emi ;Ichikawa, MasatakaNovember 17 2019 | Emerg Infect Dis. 25(11):2108-2111:In 2019, influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic gene, which confers reduced susceptibility to baloxavir, wer...
- :Meijer, Adam ;Rebelo-de-Andrade, Helena10 2014 | Antiviral Res. 110:31-41:Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is sporadic, often follows exposure to NAIs, but occasio...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.